Encéfalo/metabolismo; Regulación de la Expresión Génica/fisiología; Redes Reguladoras de Genes/fisiología; Transducción de Señal/fisiología; Tenascina/metabolismo; Animales; Humanos; Procesamiento Proteico-Postraduccional/fisiología

AD1/AD2, additional domain 1/ additional domain 2; ADAMTS, a disintegrin and metalloproteinase with thrombospondin motifs; ASMCs, aortic smooth muscle cells; BDNF, brain derived neurotrophic factor; BHKs, baby hamster kidney cells; BMP, bone morphogenetic protein; CA19­9, carbohydrate antigen 19­9; CALEB, chicken acidic leucine-rich EGF-like domain containing brain protein; CEA, carcinoembryonic antigen; CNS, central nervous system; CRC, colorectal carcinomas; CTGF, connective tissue growth factor; DCIS, ductal carcinoma in-situ; ECM, extracellular matrix; EDA-FN, extra domain A containing fibronectin; EDB-FN, extra domain B containing fibronectin; EGF-L, epidermal growth factor-like; EGF-R, epidermal growth factor receptor; ELISPOT, enzyme-linked immunospot assay; FBG, fibrinogen-like globe; FGF2, fibroblast growth factor 2; FGF4, fibroblast growth factor 4; FN, fibronectin; FNIII, fibronectin type III-like repeat; GMEM, glioma-mesenchymal extracellular matrix antigen; GPI, glycosylphosphatidylinositol; HB-EGF, heparin-binding EGF-like growth factor; HCEs, immortalized human corneal epithelial cell line; HGF, hepatocyte growth factor; HNK-1, human natural killer-1; HSPGs, heparan sulfate proteoglycans; HUVECs, human umbilical vein endothelial cells; ICC, immunocytochemistry; IF, immunofluorescence; IFNγ, interferon gamma; IGF, insulin-like growth factor; IGF-BP, insulin-like growth factor-binding protein; IHC, immunohistochemistry; IL, interleukin; ISH, in situ hybridization; LPS, lipopolysaccharide; MMP, matrix metalloproteinase; MPNSTs, malignant peripheral nerve sheath tumors; Mr, molecular mass; NB, northern blot; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells; NK, natural killer cells; NSCLC, non-small cell lung carcinoma; NSCs, neural stem cells; NT, neurotrophin; PAMPs, pathogen-associated molecular patterns; PDGF, platelet derived growth factor; PDGF-Rß, platelet derived growth factor receptor ß; PIGF, phosphatidylinositol-glycan biosynthesis class F protein; PLCγ, phospholipase-C gamma; PNS, peripheral nervous system; PTPRζ1, receptor-type tyrosine-protein phosphatase zeta; RA, rheumatoid arthritis; RCC, renal cell carcinoma; RD, rhabdomyosarcoma; RGD, arginylglycylaspartic acid; RT-PCR, real-time polymerase chain reaction; SB, Southern blot; SCC, squamous cell carcinoma; SMCs, smooth muscle cells; SVZ, sub-ventricular zone; TA, tenascin assembly domain; TGFß, transforming growth factor ß; TIMP, tissue inhibitor of metalloproteinases; TLR4, toll-like receptor 4; TNFα, tumor necrosis factor α; TSS, transcription start site; UBC, urothelial bladder cancer; UCC, urothelial cell carcinoma; VEGF, vascular endothelial growth factor; VSMCs, vascular smooth muscle cells; VZ, ventricular zone; WB, immunoblot/ western blot; bFGF, basic fibroblast growth factor; biosynthesis; c, charged; cancer; ccRCC, clear cell renal cell carcinoma; chRCC, chromophobe-primary renal cell carcinoma; development; glycosylation; mAb, monoclonal antibody; matrix assembly; mitogen-activated protein kinase, MAPK; pHo, extracellular pH; pRCC, papillary renal cell carcinoma; proteolytic cleavage; siRNA, small interfering RNA; splicing; tenascin-C; therapeutics; transcription